No Data
No Data
Private Companies Account for 57% of China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Ownership, While Individual Investors Account for 28%
Key Insights The considerable ownership by private companies in China National Accord Medicines indicates that they collectively have a greater say in management and business strategy The largest sh
China National Accord Medicines Corporation Ltd. (SZSE:000028) Passed Our Checks, And It's About To Pay A CN¥0.68 Dividend
China National Accord Medicines Corporation Ltd. (SZSE:000028) is about to trade ex-dividend in the next 3 days. The ex-dividend date is one business day before a company's record date, which is the
China National Accord Medicines Corporation (000028.SZ) announced a dividend of 6.8 yuan per share, a total of 10 dividends for 2023. The record date for A shares is June 24.
China National Accord Medicines Corporation (000028.SZ) announced that the company's annual equity distribution plan for 2023 is based on the current total share capital of 556,565,077 shares, with a cash dividend of 6.80 yuan per 10 shares (including tax) to all shareholders. The A-share equity registration day for this equity distribution is June 24, 2024, and the ex-dividend date is June 25, 2024. The last trading day of B-share equity distribution is June 24, 2024, and the ex-dividend date is June 25, 2024. The equity registration day is June 27, 2024.
China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Stock Is Going Strong: Is the Market Following Fundamentals?
China National Accord Medicines' (SZSE:000028) stock is up by a considerable 18% over the past three months. Given that the market rewards strong financials in the long-term, we wonder if that is th
China National Accord Medicines Corporation (000028.SZ): The company's main distribution business is aimed at public hospitals, and the safety of accounts receivable is relatively high.
China National Accord Medicines Corporation (000028.SZ) stated on the investor interaction platform on June 12 that the company's distribution business mainly targets public hospitals, and the security of accounts receivable is relatively high. The company attaches great importance to accounts receivable management, prudently handles accounts receivable aging, and accrues bad debt provisions in accordance with accounting policies.
China National Accord Medicines (SZSE:000028) Hasn't Managed To Accelerate Its Returns
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) an
No Data